Thanks for jolting my brain back into action - in a previous post I wrote "why is the Bayer combo drug NCE case relevant to us?" - the answer is that if we don't get NCE for V on it's own, and the FDA changes their currently flawed rules, a combo pill of V plus the NCE eligible Lipitor pro-drug molecule could potentially get NCE status. But that's far in the future....but what if we do get NCE for V, then another NCE for the combo? That's 10 years of protection from generic competition!